Comorbid anxiety in patients with psychosis

Psychiatria Danubina

Volumn 21, Issue SUPPL. 1, 2009, Pages 43-50

  Dernovšek, Mojca Zvezdana ^a   Šprah, Lilijana ^b  

^a Educational and Research Institute Ozara   (Slovenia)

^b ANTON MELIK GEOGRAPHICAL INSTITUTE   (Slovenia)

Author keywords

Comorbid anxiety; Coping; Emotional functioning; Psychosis; Treatment strategies

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; CLOMIPRAMINE; CYAMEMAZINE; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; COPING BEHAVIOR; DISEASE ASSOCIATION; HUMAN; MENTAL HEALTH SERVICE; PANIC; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL PHOBIA;

ADAPTATION, PSYCHOLOGICAL; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; ANXIETY DISORDERS; CHRONIC DISEASE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; CULTURE; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; INTERNAL-EXTERNAL CONTROL; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 70350327418     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (82)

1. American Psychiatric Association. Diagnostic and statistical classification of diseases and related health problems 4th ed. Washington DC: American Psychiatric Association, 1994.
2. Apello MT, Woonings FMJ, Sloof CJ, Carson J, Louwerens JW. Grief: Its significance for rehabilitation in schizophrenia. Clin Psychol Psychother 1993;1:24-45.
3. Barnes TR, Curson DA, Liddle FP, Patel M. The nature and prevalence of depression in chronic schizophrenic inpatients. Br J Psychiatry 1989;154-192.
4. Beck AT, Emery G & Greenberg RL. Anxiety disorders and phobias: A cognitive perspective. New York: Basic Books, 1985.
5. Beck AT, Weismann AW, Lester D, Trexler L. The assessment of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42:861-865.
6. Birchwood M & Tarrier N. Innovations in the psychological management of schizophrenia. Chicester: Wiley, 1992.
7. Baker W, Brenner HD, Würgler S. Vulnerability-linked deficiencies, psychopathology and coping behaviour of schizophrenics and their relatives. Br J Psychiatry Suppl 1989; 5:128-135
8. Bourin M, Dailly E, Hascöet M. Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome. Review. CNS Drug Rev 2004; 10(3):219-229
9. Braga RJ, Petrides G, Figueira I. Anxiety disorders in schizophrenia. Review. Compr Psychiatry 2004; 45(6):460-468
10. Brunette MF, Noordsy DL, Xie H, Drake RE. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv 2003;54(10):1395-1401 (Pubitemid 37220041)
11. Carpenter WT Jr, Buchanan RW, Kirkpatrick B, Breier AF. Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 1999;156:299-303. (Pubitemid 29077122)
12. Cassano GB, PM S, Saettoni M, Rucci P, Dell'Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry 1998; 59(2):60-68. (Pubitemid 28141237)
13. Cassano GB, Pini S, Saettoni M, Dell'Osso L Multiple anxiety disorder comorbidity in patients with mood spectrum disorders with psychotic features. Am J Psychiatry 1999; 156(3):474-476 (Pubitemid 29124174)
14. Castle DJ. Anxiety and substance use: layers of complexity. Review. Expert Rev Neurother 2008; 8(3):493-501.
15. Caldwell J, Gottesman I Schizophrenics kill themselves too. Schizophr Bull 1990; 16:571-590.
16. Chadwick PK. The stepladder to the impossible: a first hand account of a schizoaffective episode. J Mental Health 1993; 2:239-250.
17. Chen CY, Liu CY, Yang YY. Correlation of panic attacks and hostility in chronic schizophrenia. Psychiatry Clin Neurosci 2001; 55(4):383-387. (Pubitemid 32776821)
18. Craig T, Hwang MY, Bromet EJ. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry 2002; 159(4):592-598 (Pubitemid 34274941)
19. Cosoff SJ, Hafner RJ. The prevalence of comorbid anxiety in schizophrenia, schizoaffective and bipolar disorder. Austr N Z J Psychiarty 1998;32 :67-72.
20. De Haan, Beuk N, Hoogenboom B, Dingemans P, Linszen D. Obsessive-compulsive symptoms observed during treatment with Olanzapine and Risperidone: A prospective study of 113 patients with recent onset schizophrenia or related disorders. J Clin psychiatry 2002; 63:104-107. (Pubitemid 34173845)
21. Denis C, Fatséas M, Lavie E, Auriacombe M. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Review. Cochrane Database Syst Rev 2006; 3:CD005194.
22. Drake RE, Cotton PG. Depression and hopelessness and suicide I in chronic schizophrenia. Br J psychiatry 1986; 148:554-559. (Pubitemid 16042302)
23. Emsley RA, Oosthuisen PP, Joubert AF, Roberts MC, Stein DJ. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry 1999; 60:747-751.
24. Es troffSE. Self, identity and subjective experiences of schizophrenia. Schizophr Bull 1989;15:179-196.
25. Fowler D, Garety P, Kuipers E. Cognitive behaviour therapy for psychosis. Chicester: Wiley, 1999.
26. Fowler D, Morley S. The cognitive-behavioural treatment of hallucinations and delusions: a preliminary study. Behav Psychother 1989; 17:267-282. (Pubitemid 19229691)
27. Frame L, Morrison AP. Causes of posttraumatic stress disorder in psychotic patients. Arch Gen Psychiatry 2001; 58(32):305-306.
28. Gillies D, Beck A, McCloud A, Rathbone J, Gillies D. Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis. Cochrane Database Syst Rev. Review. 2005;(4):CD003079.
29. Goodwin R, Lyons JS, McNally RJ. Panic attacks in Schizophrenia. Schizophr Res 2002; 58:213-220.
30. Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM. Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res 2003; 61(1):89-95. (Pubitemid 36332143)
31. Goldberg SC, Schooler NR, Hogarty GE & Collaborative Study Group: Prediction of relapse in schizophrenic out-patients treated by drugs and sociotherapy. Arch Gen Psychiatry 1977; 34:171-184.
32. Hansson L. Determinants of quality of life in people with severe mental illness. Review.Acta Psychiatr Scand Suppl. 2006;(429):46-50.
33. Hartman E, Milofsky E, Vailant GM et al: Vulnerability to schizophrenia: prediction of adult schizophrenia using childhood information. Arch Gen Psychiatry 1984;41:1959-11056
34. Hendriks GJ, Oude Voshaar RC, Keijsers GP, Hoogduin CA, van Balkom AJ. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Review. Acta Psychiatr Scand 2008; 117(6):403-411
35. Herbener ES, Song W, Khine TT, Sweeney JA. What aspects of emotional functioning are impaired in schizophrenia? Schizophr Res 2008, 98(1-3):239-246
36. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE. Quality of life in Schizophrenia: contribution of anxiety and depression. Schizophr Res 2001;51:171-180. (Pubitemid 32772850)
37. Huppert JD, Smith TE. Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. J Nerv Ment Dis 2001;189(10):669-675
38. Janssen I, Krabbendam L, Bak M, Hanssen M, Vollebergh W, de Graaf R, van Os J. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand 2004; 109:38-45. (Pubitemid 38161099)
39. Johnson DAW. Studies of depressive symptoms in schizophrenia. Br J Psychiatry 1981; 139:89-101.
40. Johnson DAW. The significance of depression in the prediction of relapse in chronic schizophrenia. Br J Psychiatry 1988;152:320-323. (Pubitemid 18077892)
41. Kaplan HI, Sadock BJ. Anxiety disorders. In: Kaplan HI, Saduck BJ, eds. Comprehensive textbook of psychiatry. 6th ed. Baltimore: Williams & Wilkins, 1995.
42. Kingdon DG, Turkington D. The use of cognitive behavioural therapy with normalising rationale in schizophrenia. J Nerv Ment Dis 1991; 179:207-211.
43. Kingdon DG, Turkington D. Cognitive behavioural therapy in schizophrenia. Hove, Lawrence Erlbaum, 1994.
44. Kingsep P, Nathan P, Castle D. Cognitive behavioural group treatment for social anxiety in schizophrenia. Schizophr Res 2003; 63(1-2): 121-129. (Pubitemid 36929854)
45. Knapp M, Mangalore R, Simon J. The global costs of schizophrenia. Schizophr Bull 2004; 30:279-293.
46. Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J. Prevalence of obsessive compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci 2000; 12:16-24. (Pubitemid 30093684)
47. Kuipers E, Garety P, Fowler D, Freeman D, Dunn G, Bebbington P. Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms. Review.Schizophr Bull 2006; 32 Suppl 1:S24-31.
48. Kuipers E, Bebbington P.Cognitive behaviour therapy for psychosis. Review. Epidemiol Psichiatr Soc 2006; 15(4):267-275
49. Labbate LA, Young PC, Arana GW. Panic disorder in Schizophrenia. Can J Psychiatry 1999; 44:488-490.
50. Lançon C, Auquier P, Reine G, Bernard D, Addington D. Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period. Schizophr Re. 2001; 47(2-3):135-140 (Pubitemid 32244097)
51. Lysaker PH, Salyers MP. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatr Scand 2007;116(4):290-298
52. Lysaker PH, Davis LW, Gatton MJ, Herman SM. Associations of anxiety-related symptoms with reported history of childhood sexual abuse in schizophrenia spectrum disorders. J Clin Psychiatry 2005; 66(10):1279-1284
53. Lysaker PH, Salyers MP. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history. Acta Psychiatr Scand 2007;116(4):290-298
54. MacCarthy B, Benson J, Brewin CR. Task motivation and problem appraisal in long-term psychiatric patients. Psychol Med 1986; 16:431-438. (Pubitemid 16119207)
55. McCue RE. Waheed R. Urcuyo L. Polypharmacy in patients with schizophrenia. Journal of Clinical Psychiatry 2003; 64(9):984-989
56. Margetic B. Aggravation Of Schizophrenia By Clomipramine In A Patient With Comorbid Obsessive-compulsive Disorder. Psychopharmacol Bull 2008;41(2):9-11.
57. Müller JE, Koen L, Soraya S, Emsley RA, Stein DJ. Anxiety disorders and schizophrenia. Review. Curr Psychiatry Rep 2004;6(4):255-261
58. Moorley H, Soni SD. Anxiety symptoms in stable chronic schizophrenic. J Ment Health 1994; 3:257-262.
59. Neria Y, Bromet EJ, Sievers S, Lovelle J, Fochtmann LJ. Trauma exposure and post traumatic stress disorder in psychosis: findings from a first admission cohort. J Consult Clin Psychol 2002; 70:246-251. (Pubitemid 34150992)
60. Pallanti S, Quercioli L, Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry 2004;161(1):53-58. (Pubitemid 38419307)
61. Pallanti S, Quercioli L, Rossi A, Pazzagli A. The emergence of social phobia during Clozapine treatment and its response to Fluoxetine augmentation. J Clin Psychiatry 1999; 60:819-823.
62. Patterson TL, Leeuwenkamp OR. Adjunctive psychosocial therapies for the treatment of schizophrenia. Review. Schizophr Res 2008; 100(1-3):108-119
63. Poyurovsky M, Dorfman-Etrog P, Hermesh H, Munitz H, Tollefson GD, Weizman A. Beneficial effect of Olanzapine in Schizophrenic patients with obsessive compulsive symptoms. Int Clin Psychopharmacol 2000; 15:169-173. (Pubitemid 30326052)
64. Poyurovsky M, Hramenkov S, Isakov V, Rauchverger B, Modai I, Schneidam M, Fuchs C, Weizman A. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res 2001; 102:49-57. (Pubitemid 32463924)
65. Rahman MS, Grace JJ, Pato MT, Priest B. Sertraline in the treatment of clozapine-induced obsessivecompulsivebehavior. Am J Psychiatry 1998;155(11):1629-1630
66. Shaw K, McFarlane A, Bookless C. The phenomenology of traumatic reactions to psychotic illness. J Nerv Ment Dis 1997; 185(7):434-441 (Pubitemid 27313835)
67. Shepherd G. The contribution of psychological intervention to the treatment and management of schizophrenia. In: Bebington P& McGuffin P, eds. Schizophrenia: the major issues. Oxford, Heinemann, 1988.
68. Schatzberg AF. New approaches to managing psychotic depression. Review. J Clin Psychiatry 2003;64 Suppl 1:19-23.
69. Shevlin M, Houston JE, Dorahy MJ, Adamson G. Cumulative traumas and psychosis: an analysis of the national comorbidity survey and the British Psychiatric Morbidity Survey. Review. Schizophr Bull 2008; 34(1):193-199
70. Siris SG: Diagnosis of secondary depression in schizophrenia. Schizophr Bull 1991; 17:75-89.
71. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092-1097 (Pubitemid 43765180)
72. Sumiyoshi T, Jayathilake K, Meltzer HY. The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia. Schizophr Res 2003; 59(1):7-16. (Pubitemid 35284488)
73. Teasdale JD, Barnard PJ. Affect, cognition and change. Hove, Lawrence Erlbaum, 1991.
74. Turnball G, Bebbington P. Anxiety and the schizophrenic process: clinical and epidemiological evidence. Soc Psychiatry Psychiatr Epidemiol 2001; 36:235-243. (Pubitemid 32694468)
75. Vauth R, Kleim B, Wirtz M, Corrigan PW. Self-efficacy and empowerment as outcomes of self-stigmatizing and coping in schizophrenia. Psychiatry Res 2007; 150(1):71-80. (Pubitemid 46281341)
76. Velligan DI, Gonzalez JM. Rehabilitation and recovery in schizophrenia. Review. Psychiatr Clin North Am 2007; 30(3):535-548
77. Watson PW, Garety PA, Weinman J, Dunn G, Bebbington PE, Fowler D, Freeman D, Kuipers E. Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions. Psychol Med 2006; 36:761-770. (Pubitemid 43744769)
78. Wetherell JL, Palmer BW, Thorp SR, Patterson TL, Golshan S, Jeste DV. Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2003;64(12):147 6-82.
79. Wiedl KH, Schottner B: Coping with symptoms related to schizophrenia. Schizophr Bull 1991; 17:525-538.
80. Wing JK Social influences on the course of schizophrenia. In: Wirt DR, Winokur G & Rolf G, eds. Life history and psychology, volume 4. Mineapolis, University of Minnesota Press, 1975.
81. Wing JK. Schizophenia. In: Wats FN, Bennett DH, eds. Theory and practice of psychiatric rehabilitation. Chicester, Willey, 1983.
82. Wing JK Psychological factors affecting the long-term course of schizophrenia. In: Strouss JS, Boker W, Brenner HD, eds. Psychosocial treatment of schizophrenia. Toronto, Huber, 1987.